South San Francisco, United States
Genentech, founded in 1976 and headquartered in the United States, is a pioneering biotechnology company dedicated to discovering, developing, manufacturing, and commercializing innovative medicines. Their mission is to address some of the world's most challenging medical conditions through cutting-edge science.
While Genentech is well-established in the industry, their last noted financial milestone was a $22.60M grant investment from the HHS Administration for Strategic Preparedness and Response in June 2020. This underscores their ongoing collaboration with government bodies to enhance health readiness and response capabilities.
From an investment perspective, Genentech stands out for its robust scientific commitment and its potential to make a significant global health impact. The company's focus on fostering innovation, regulated community guidelines, and engagement through a patient resource center are key value propositions for stakeholders interested in long-term, health-related investments.
